EyePoint Pharmaceuticals, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
EyePoint Pharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to 2023.
  • EyePoint Pharmaceuticals, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $115K.
  • EyePoint Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $187M.
  • EyePoint Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$690K, a 100% decline from 2021.
  • EyePoint Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $217M, a 479% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $187M +$188M Jan 1, 2023 Dec 31, 2023 10-K 2024-03-08
2022 -$690K -$218M -100% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-08
2021 $217M +$179M +479% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-10
2020 $37.5M +$3.63M +10.7% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-14
2019 $33.9M -$26.8M -44.2% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-12
2018 $60.7M +$52.2M +614% Jul 1, 2017 Jun 30, 2018 10-K 2020-03-16
2017 $8.5M -$8.49M -50% Jul 1, 2016 Jun 30, 2017 10-K 2020-03-16
2016 $17M Jul 1, 2015 Jun 30, 2016 10-KT 2019-03-18
2013 $4.67M +$4.56M +3996% Jul 1, 2012 Jun 30, 2013 10-K 2013-09-27
2012 $114K -$9.95M -98.9% Jul 1, 2011 Jun 30, 2012 10-K 2013-09-27
2011 $10.1M +$9.26M +1154% Jul 1, 2010 Jun 30, 2011 10-K 2013-09-27
2010 $802K Jul 1, 2009 Jun 30, 2010 10-K 2012-09-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.